How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

0 Ratings
0
Episode
263 of 286
Duration
31min
Language
English
Format
Category
Non-fiction

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.


Listen and read

Step into an infinite world of stories

  • Read and listen as much as you want
  • Over 1 million titles
  • Exclusive titles + Storytel Originals
  • 7 days free trial, then €9.99/month
  • Easy to cancel anytime
Try for free
Details page - Device banner - 894x1036
Cover for How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Other podcasts you might like ...